Smithers Apex presents a 3 Day MBA on Industrial Biotechnology
16 February 2012
Advance your career at the world's first 3-day MBA on Industrial Biotechnology
Leatherhead UK, 16 February 2012. The world's first 3-day MBA on industrial biotechnology will take place on March 13-15th 2012 at the Royal College of Surgeons, London, UK (www.3-day-mba.com).
Specially designed to fuel career growth in the dynamic and challenging biobased economy, the 3-day MBA in Industrial Biotechnology offers teaching by world experts in a fast paced and interactive environment.
The 3-day MBA is organised by Smithers Apex, who manage the hugely successful EFIB conference (www.efibforum.com) and publish market studies on industrial biotechnology and bioplastics.
Industrial Biotechnology offers an exciting new opportunity to drive real growth, reach new markets, reduce costs and meet sustainability objectives. Industrial Biotechnology, sometimes known as White Biotechnology, is a key enabling technology in the biobased economy and is already transforming the way chemicals, plastics and other materials are made.
According to Adam Page, Business Manager at Smithers Apex, "Interest in the world's first 3-day MBA on Industrial Biotechnology has been phenomenal. There is a real thirst for high-level training on this emerging industry."
Space is limited to maintain the quality of the teaching and allow for highest quality interactions between delegates and tutors.
Training is led by Dirk Carrez, former Director Industrial Biotechnology at EUROPABIO (The European Association for BioIndustries). In his previous role, Dirk coordinated the activities in the area of industrial biotechnology and the "biobased economy", as well as horizontal issues, such as research & innovation, SMEs & access to finance, IPR, etc.
Since the beginning of 2011, Dirk has been the Associate Consultant at Smithers Apex for industrial biotech related issues, and supports the strategy and business development of BIO BASE EUROPE, one of the first open innovation and education centers for the biobased economy in Europe.
Other faculty include Bruno Ferreira and Martin Austin. Bruno Ferreira has a strong and broad bioengineering background, and is experienced in diverse areas like microalgae, the optimization microbial processes and the development of culture systems for stem cells. Martin Austin is a member of the UK Knowledge Transfer Network in Industrial Biotechnology, a representative to the OECD task force on Industrial Biotechnology and an advisor to Europabio which represents the European Commission's interests in Industrial Biotechnology.
Many leading players in the chemical sector (e.g. BASF, Dupont, Evonik and DSM) as well as a growing number of smaller companies and new ventures are already active in this sector, and many more are joining. As momentum gathers pace it is critical to have a thorough understanding of the key technologies, the opportunities they represent for your business and how to invest your resource most effectively to capitalise on these new markets.
This 3-day MBA course on Industrial Biotechnology will help you get quickly up to speed on the potential opportunities in this marketplace and help you focus on how your company could benefit from these exciting developments.
The remaining places at the 3-day MBA industrial biotechnology are available to book now. Places cost £3,299, but delegates can save £300 by booking before 29 February. For further information please contact Stephen Frier on +44 (0) 1372 802 006, stephen.frier@smitherspira.com
Press contact: for editorial queries or an expanded article, please contact:
Chandra Guyot, T: + 207-781-9602, chandra.guyot@smitherspira.com
Smithers Apex provides market research, strategic and technical consulting to niche, emerging and high growth industries. Market coverage of other reports includes lighting and displays, clean energy, home and personal care, industrial biotechnology, performance materials and chemicals. Smithers Apex is a division of Smithers Pira.